Stoke Therapeutics CMO exercises 10,000 stock units
Stoke Therapeutics, Inc. (STOK) reported insider equity activity by its Chief Medical Officer, Barry Ticho.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Stoke Therapeutics, Inc. (STOK) reported insider equity activity by its Chief Medical Officer, Barry Ticho. On August 14, 2026, he exercised 10,000 performance stock units, receiving 10,000 shares of common stock at a price of $0.00 per share. On August 18, 2026, the company facilitated issuer-mandated sales of 4,525 and 242 common shares, respectively, to satisfy tax withholding liabilities tied to restricted stock unit vesting, at weighted average prices around $32 per share across specified price ranges.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Ticho Barry
Role
CHIEF MEDICAL OFFICER
Sold
4,767 shs ($153K)
Approx. gross sale proceeds
$153K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 4,525 | $32.0072 | $145K |
| Sale | Common Stock F1, F3 | 242 | $32.4681 | $8K |
| Exercise | Performance Stock Units F4, F5 | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $0.00 | $0.00 |
Holdings After Transaction:
Performance Stock Units — 0 contracts (Direct);
Common Stock — 25,655 shares (Direct)
Footnotes (5)
- F1. The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.
- F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.40 to $32.36 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4.
- F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.44 to $32.54 per share, inclusive.
- F4. Each performance stock unit represents a right to receive one share of the Issuer's common stock.
- F5. Achievement of this performance stock unit award was certified on August 14, 2025. Pursuant to the terms of the award agreement between the reporting person and the Issuer, half the award vested on August 14, 2025 and the remainder vests on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date.
Key Figures
Shares sold (tax withholding): 4,525 shares
Additional shares sold (tax withholding): 242 shares
Weighted average sale price 1: $32.0072 per share
+5 more
8 metrics
Shares sold (tax withholding)
4,525 shares
Common stock sold on August 18, 2026 to satisfy tax withholding liabilities
Additional shares sold (tax withholding)
242 shares
Common stock sold on August 18, 2026 to satisfy tax withholding liabilities
Weighted average sale price 1
$32.0072 per share
Weighted average for sales between $31.40 and $32.36 per share
Price range 1
$31.40–$32.36 per share
Range for the larger August 18, 2026 sale
Weighted average sale price 2
$32.4681 per share
Weighted average for sales between $32.44 and $32.54 per share
Price range 2
$32.44–$32.54 per share
Range for the smaller August 18, 2026 sale
Performance stock units exercised
10,000 units
PSUs exercised on August 14, 2026 into common stock
Underlying common shares from PSUs
10,000 shares
Each performance stock unit convertible into one share of common stock
Key Terms
performance stock unit, weighted average price, tax withholding liabilities, restricted stock units
4 terms
performance stock unit financial
"Each performance stock unit represents a right to receive one share"
A performance stock unit is a type of reward companies give to employees, usually managers, that depends on how well the company performs over time. If the company hits specific goals, the employee earns shares of stock, like earning a prize for reaching certain levels in a game. It motivates employees to work hard because their rewards are tied to the company's success.
weighted average price financial
"The reported price in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
tax withholding liabilities financial
"sale to satisfy tax withholding liabilities in connection with the vesting"
restricted stock units financial
"in connection with the vesting and settlement of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did STOK’s Chief Medical Officer report on this Form 4?
Barry Ticho reported exercising 10,000 performance stock units into common stock and issuer-mandated sales of 4,525 and 242 shares to cover tax withholding liabilities related to restricted stock unit vesting.
What did the 10,000 performance stock units convert into for STOK’s CMO?
Each performance stock unit represented a right to receive one share of common stock, so 10,000 PSUs converted into 10,000 shares of Stoke Therapeutics common stock at an effective exercise price of $0.00 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
